Dölle-Bierke, Sabine
Plank-Habibi, Sibylle
Schäfer, Christiane
Ahrens, Birgit
Ballmer-Weber, Barbara
Beyer, Kirsten
Blümchen, Katharina
Huttegger, Isidor
Jappe, Uta
Kleine-Tebbe, Jörg
Lange, Lars
Lau, Susanne
Lepp, Ute
Mahler, Vera
Müller, Sabine
Saloga, Joachim
Schnadt, Sabine
Szepfalusi, Zsolt
Treudler, Regina
Wassmann-Otto, Anja
Werfel, Thomas
Zuberbier, Torsten
Reese, Imke
Worm, Margitta
Funding for this research was provided by:
Charité
Article History
Received: 13 November 2019
Accepted: 5 December 2019
First Online: 11 May 2020
Conflict of interest
: J. Kleine-Tebbe has received grants and/or honoraria from AllergenOnline (Nebraska, USA), Allergy Therapeutics, Allergopharma, ALK-Abelló, AstraZeneca, personal fees from Bencard, Dr. Pfleger, GSK, HAL Allergy, InfectoPharm, LETI, Lofarma, Novartis, Merck US, Sanofi Genentech, Stallergenes-Greer, Springer International Publishers, ThermoFisher Scientific, and Thieme Publishers, Germany. He has also received support (non-financial) from the American Academy of Allergy Asthma and Immunology, the European Academy of Allergy and Clinical Immunology, and the WHO/IUIS Allergen nomenclature subcommittee. He has received honoraria and support (non-financial) from the German Society for Allergology and Clinical Immunology—all outside the present work. S. Lau has received honoraria from ALK, DBV, Sanofi Genzyme and Allergopharma, outside the present work. U. Lepp has received honoraria from Chiesi, ALK-Abelló, Bencard Allergie, Novartis Pharma GmbH, Grifols, MedaPharm, and CGC-Cramer, outside the present work. S. Müller has received honoraria from Novartis GmbH and Bencard GmbH, outside the present work. R. Treudler has received grants and/or honoraria from Sanofi-Genzyme, ALK-Abelló, Takeda, Novartis, and the Hautnetz Leipzig. R. Treudler also declares a scientific collaboration with and financial compensation from the Fraunhofer-IZI Leipzig—all outside the present work. M. Worm has received lecture fees, was active as a consultant and member of the advisory board, and has given lectures for the following companies: Mylan Germany, ALK-Abelló Arzneimittel, Allergopharma GmbH & Co. KG, HAL Allergie, Stallergenes GmbH, and Bencard Allergie, outside the present work. T. Zuberbier declares that he is active for the WHO initiative “Allergic Rhinitis and Its Impact on Asthma” (ARIA), the German Society for Allergology and Clinical Immunology (DGAKI), the European Centre for Allergy Research Foundation (ECARF), the Global Allergy and Asthma European Network (GA2LEN), the Committee on Allergy Diagnosis and Molecular Allergology, and the World Allergy Organization (WAO). S. Dölle-Bierke, S. Plank-Habibi, C. Schäfer, B. Ahrens, B. Ballmer-Weber, K. Beyer, K. Blümchen, I. Huttegger, U. Jappe, L. Lange, V. Mahler, J. Saloga, S. Schnadt, Z. Szepfalusi, A. Wassmann-Otto, T. Werfel and I. Reese declare that they have no competing interests.